Check out your Company Bowl for anonymous work chats.
🎯 Announcing our new GLP-1 prescribing offering: where clinical excellence meets behavior change. Built on insights from serving 100K+ GLP-1 members, our integrated approach combines: ⭐ Prescribing and medication management ⭐ Evidence-based behavior change ⭐ Coordinated care between visits Learn more: https://lnkd.in/gk5Txcy8
Today, we're excited to share $OMDA's Q3 2025 results, marking our first quarter of positive Adjusted EBITDA: 📈 Revenue up 49% year over year to $68M 👥 Member growth of 53% year over year to 831K members 📊 GAAP Net Loss narrowed to $3M 💫 Positive Adjusted EBITDA of $2M Alongside these results, we announced our new prescribing offering and continued innovation in AI-powered nutrition support with Meal Map. Our member's voice says it best: "Having struggled with weight for most of my life, I realize there is no quick fix... Omada has been very helpful in getting me thinking about what I can do to better my life, now and in the future." Read more about our Q3 performance, including a reconciliation of GAAP to Non-GAAP measures: https://buff.ly/hpBKj3p
November is #DiabetesAwarenessMonth. As a digital diabetes prevention provider over the last decade, we’ve seen first-hand how diabetes doesn’t “act” alone. Our Omada for Diabetes members often manage multiple chronic conditions at the same time, requiring care that adapts to their individual circumstances. One co-condition of diabetes is heart disease. In fact, people with diabetes are two to four times more likely to develop cardiovascular disease. In this month’s Proof Points, Diabetes Care Team Senior Manager Carolyn Salter, RD, LD, CDCES dives into the connection between diabetes and high cholesterol, the importance of knowing your numbers, and why accepting support is crucial for reducing your risk of complications. Read here and share with someone who could benefit from this information.
We’re excited to share our real-world evidence being presented at The Obesity Society’s Obesity Week 2025 that demonstrated how Omada's program enhances outcomes for GLP-1 users: 📈 Increased persistence - with 84% still taking GLP-1s at 24 weeks 🎯 63.2% maintained or continued losing weight at 12 months after stopping medication 💡 Higher engagement led to 54% better odds of staying on medication These findings show that wraparound lifestyle support can make a significant difference in both medication persistence and long-term weight management. Read the full announcement: https://lnkd.in/eT_Dg7TN hashtag#ObesityWeek hashtag#OW2025
While clinical trials show people average a ~12% weight gain in their first year off GLP-1s, Omada members see an average weight change of just 0.8%. Read more in our full 12-month discontinuation findings. https://lnkd.in/ezwH9E6Q
For the 43% of Americans living with obesity, exercise may not be an issue of “want to.” It’s a matter of finding the right support. As the popularity of GLP-1s grows, so does the need for effective companion programs that emphasize MSK care and avoiding muscle loss that threaten long-term weight health outcomes. Read more. https://lnkd.in/eNCenMHa
We're excited to welcome Thomas Tsang, MD, MPH as Omada Health's new Chief Medical Officer! Dr. Tsang brings an exceptional blend of clinical, academic, and policy expertise to Omada. As founding CEO of Valera Health, he scaled virtual behavioral healthcare delivery while maintaining clinical excellence. His experience includes shaping national health IT policy as Medical Director at Office of the National Coordinator for Health Information Technology and contributing to the Affordable Care Act. Dr. Tsang currently serves on the boards of Blue Cross and Blue Shield of Kansas City and the National Committee for Quality Assurance (NCQA) As CMO, Dr. Tsang will lead our clinical organization, advancing clinical quality, strategy, outcomes, and innovation across our multi-condition platform. Please join us in welcoming Dr. Tsang to the Omada team! https://lnkd.in/eVZXsrvp
Our team showed up big at #HLTHUSA this week! What did we get up to? ✨ Connecting with partner Benefitfocus, prospects and customers alongside Elvis at Omada’s happy hour ✨ Daily demos from health coach Kristin Crawford, PT, MPT, CFNIP as we launched our new campaign “Who’s In Your Corner,” showcasing the heart of the program - our human care team ✨ CEO and Co-Founder Sean Duffy spoke on a panel about the path to Omada’s recent IPO Thank you, HLTH USA for an opportunity to innovate together on the future of digital health! Here’s to Bending the Curve together 💫
Omada members who got off GLP-1s had a great year maintaining their weight loss results. It was a year that might even make NBA superstar Steph Curry jealous. How are you supporting your members during (and after) their GLP-1 journey? Learn more about Omada’s approach and results in our full 12-month GLP-1 discontinuation report. https://lnkd.in/eAEq6H56
Calories vs. Nutrients: What really counts toward your health? It’s true that eating fewer calories can result in weight loss, but when it comes down to it, a smaller body isn’t always a healthier body. Director of Clinical Product Alison Megliola, MS, RD, CDCES explains why.
